Suppr超能文献

全身皮肤电子束照射和全淋巴结照射治疗皮肤T细胞淋巴瘤患者。

Total skin electron beam and total nodal irradiation for treatment of patients with cutaneous T-cell lymphoma.

作者信息

Micaily B, Vonderheid E C, Brady L W, Andrews C

出版信息

Int J Radiat Oncol Biol Phys. 1985 Jun;11(6):1111-5. doi: 10.1016/0360-3016(85)90057-4.

Abstract

Sixteen patients with advanced cutaneous T-cell lymphoma (CTCL) with or without lymph node involvement, but without evidence of extranodal manifestations, were treated with a combination of total skin electron beam therapy (TSEB) and total nodal irradiation (TNI). Fourteen (87%) patients achieved a complete response (CR) lasting from 1 to 84+ months (median, 8+ months) from the completion of treatment. The best results occurred in 6 patients with pretumorous intracutaneous CTCL (Stages IB and IIA) where the CR has lasted in all patients from 8 to 84+ months (median about 27+ months). Conversely, a long-term CR occurred in only one of five patients with tumor-phase intracutaneous CTCL (Stage IIB) and in none of the 5 patients with histopathologically proven nodal involvement (Stage IVA). Radiotherapy was well tolerated with the major toxicity being bone marrow suppression. We conclude that combined TSEB and TNI is a relatively safe and effective treatment for patients with CTCL prior to the development of lymph node involvement. Long-term follow-up is needed to assess the curative potential of this treatment.

摘要

16例晚期皮肤T细胞淋巴瘤(CTCL)患者,有或无淋巴结受累,但无结外表现证据,接受了全身皮肤电子束治疗(TSEB)和全淋巴结照射(TNI)联合治疗。14例(87%)患者在完成治疗后达到完全缓解(CR),持续时间为1至84 +个月(中位数为8 +个月)。最佳结果出现在6例肿瘤前期皮内CTCL(IB期和IIA期)患者中,所有患者的CR持续时间为8至84 +个月(中位数约为27 +个月)。相反,5例肿瘤期皮内CTCL(IIB期)患者中只有1例出现长期CR,5例组织病理学证实有淋巴结受累(IVA期)的患者均未出现长期CR。放疗耐受性良好,主要毒性为骨髓抑制。我们得出结论,对于CTCL患者在出现淋巴结受累之前,TSEB和TNI联合治疗是一种相对安全有效的治疗方法。需要长期随访来评估这种治疗的治愈潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验